Logo

Genaissance Pens PGx Agreement with Ferring Pharmaceuticals

Dec 11, 2003

NEW YORK, Dec. 11 (GenomeWeb News) - Genaissance Pharmaceuticals will provide Ferring Pharmaceuticals certain pharmacogenomic services and technology, the companies said today.

Terms of the agreement call for Genaissance to provide Ferring its DNA banking services through its Morrisville, NC, facility. Genaissance will also collaborate with Ferring to identify clinical projects for the application of its HAP technology.

Breaking News
The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.